Replies to post #7855 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

"Abbott's Molecular Diagnostics and Diabetes Care (glucose monitoring) businesses are not part of the transaction and will remain part of Abbott."


I think you are correct. They did not sell the molecular tests.

[Gold Seeker]

http://www.abbottmolecular.com/AbbottDedicatesNewMolecularDiagnosticsHeadquartersInDesPlainesIll_356....

It looks like the link is the molecular diagnostics they did not sell. It would be at this location where RECAF should be in development. It would appear they are keeping the mass analyzers also but not sure on that. The whole deal is a little confusing.

It looks like they just opened this facility in Sept 2005 so if they moved the development of RECAF from another location, it could have slowed the process.

"About Abbott Molecular Diagnostics
Abbott's rapidly growing molecular diagnostics business provides physicians with critical information based on the early detection of pathogens and subtle changes in patients' genes and chromosomes, allowing for earlier diagnosis, selection of appropriate therapies and monitoring of disease progression. The business includes instruments and reagents used to conduct sophisticated analysis of patient DNA and RNA."